Femara 2.5mg (Letrozole Tablet) 2.5mg

Femara 2.5mg (Letrozole) is an aromatase inhibitor tablet used to reduce estrogen levels in postmenopausal women. It is commonly prescribed for hormone receptor-positive breast cancer treatment and prevention. This 30-tablet pack is stored at room temperature and manufactured by Novartis.

Strength

2.5mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Novartis Pharma Stein AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Femara 2.5mg is primarily used to treat hormone receptor-positive breast cancer in postmenopausal women. It works by lowering estrogen levels in the body, which can slow or stop the growth of certain breast cancers. This medication may also be used to reduce the risk of cancer recurrence after initial treatment.

Side Effects

Common effects of Femara 2.5mg include hot flashes, joint pain, and fatigue. Some users may experience mild nausea or headaches as the body adjusts to the medication. These effects are typically temporary and vary by individual.

Precautions & Warnings

Femara 2.5mg should be handled with care, especially by those with a history of osteoporosis or bone fractures. Regular bone density monitoring may be recommended during treatment. Keep the medication in its original packaging and store at room temperature, away from moisture and heat.

Avoid Interactions

Femara 2.5mg may interact with other medications that affect estrogen levels, such as hormone replacement therapies. Caution is advised when combining it with drugs that are metabolized by the liver, as this could alter its effectiveness. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Femara 2.5mg is used to treat hormone receptor-positive breast cancer in postmenopausal women.

Store Femara 2.5mg at room temperature in its original packaging, away from moisture and heat.

Common side effects include hot flashes, joint pain, fatigue, mild nausea, and headaches.

Yes, it may interact with hormone therapies or drugs metabolized by the liver; consult a healthcare provider.

Femara 2.5mg is typically prescribed for postmenopausal women; suitability depends on individual health factors.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.